Federal Circuit Reverses, Says ‘Vimovo’ Patents Insufficiently Descriptive

Mealey's (May 16, 2019, 1:07 PM EDT) -- WASHINGTON, D.C. — A New Jersey federal judge’s finding that two patents covering the pain-reliever drug “Vimovo” are adequately described under Section 112 of the Patent Act, 35 U.S.C. § 112,...
To view the full article, register now.